Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high26.62 25/05/17
52 week low15.00 13/02/18
52 week change -1.63 (-9.45%)
4 week volume1,369,153 27/01/18
price15.60
price date1519306088
close16.00

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
06/07/2015
Presenter: Kieron Harbinson, Group Finance Director
14/04/2015

Latest NewsMore

Holding(s) in Company

RNS Number: 7661B Omega Diagnostics Group PLC 12 January 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Omega...

Omega extends Allersys menu

Omega, the medical diagnostics company, has CE-Marked an additional eight allergens to extend its menu to 49 allergens. T...

Allersys? CE-Mark

RNS Number: 9977Z Omega Diagnostics Group PLC 21 December 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") Allersys CE-Mark Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked an additional eight allergens to extend its menu to 49 allergens. Ome...

Broker Forecast - finnCap issues a broker note on Omega Diagnostics Group PLC

finnCap today reaffirms its corporate investment rating on Omega Diagnostics Group PLC (LON:ODX) and cut its price t...

Omega CEO steps down

Omega Diagnostics' Andrew Shepherd has agreed to step down as chief executive officer and from the board with immed...

Omega revenue up 4%

Omega Diagnostics, the medical diagnostics, increased its revenue by 4% to 7.11m in the six months ended 30 September. Foo...

CEO succession

RNS Number: 3006Z Omega Diagnostics Group PLC 14 December 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") CEO succession Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that as part of Omega's Board succession planning, Andrew Shepherd has agreed to step down...

Interim results

RNS Number: 3004Z Omega Diagnostics Group PLC 14 December 2017 OMEGA DIAGNOSTICS GROUP PLC ("Omega" or the "Company" or the "Group") INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2017 Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces its un...

Fundamental DataMore

P/E ratio22.286
EPS0.7
Dividend yield0 %

Latest discussion posts More

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account